CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,689,493
- in 1 filing, $1.7M under 10b5-1 plans
Net −$1,689,493. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-02 | Ratcliffe Liam Director | Grant or award · Stock Option (Right to Buy) | +4,860 | $2.70 | $13K | 4,860 |
| 2019-01-02 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +4,397 | $2.70 | $12K | 4,397 |
| 2019-01-02 | Ferrante Karen Jean Director | Grant or award · Stock Option (Right to Buy) | +4,073 | $2.70 | $11K | 4,073 |
| 2019-01-02 | Booth Bruce Director | Grant or award · Stock Option (Right to Buy) | +6,757 | $2.70 | $18K | 6,757 |
| 2019-01-02 | Aldag Jorn Director | Grant or award · Stock Option (Right to Buy) | +4,999 | $2.70 | $13K | 4,999 |
| 2018-12-26 | Ettenberg Seth Chief Scientific Officer | Option exercise | +11,485 | $0.18 | $2K | 11,485 |
| 2018-12-26 | Ettenberg Seth Chief Scientific Officer | Sale | −11,485 | $4.05 | $46K | 0 |
| 2018-12-26 | Ettenberg Seth Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −11,485 | 352,115 |
Page 14 of 14 · 268 trades